Retroperitoneal laparoscopic radical nephrectomy in the treatment of renal cancer: a 5-year single-center experience in resource-scare setting

Published: 8 July 2024
Abstract Views: 102
PDF: 48
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Based on a retrospective hospital-based analysis, this study examines the results of retroperitoneal laparoscopic radical nephrectomy for patients with T1-T2 renal cell carcinoma (RCC) from January 2019 to December 2023. Of the 73 patients, 4.1% had TNM stage II tumors and 95.8% had TNM stage I tumors (53.4% T1a and 42.4% T1b). In terms of frequency, clear cell RCC accounted for 84.9%, with papillary RCC coming in at 9.6% and chromophobe RCC at 4.1%. Following surgery, four patients experienced fevers, one needed a blood transfusion, two had infections, and one had emergency surgery. Lumbar masses and hematuria were absent in all patients. Subsequent metastatic lesions and abnormalities of the renal fossa were not observed on follow-up ultrasounds. 4.1% of the deaths after 25.9 months were due to the disease, and 1.4% were caused by accidents. At one, two, three, and four years, the cumulative survival rates were 100%, 97.2%, and 92.8%, respectively. 48.1 months was the mean postoperative survival period. For RCC stages T1-2, retroperitoneal laparoscopic radical nephrectomy offers significant benefits and comparable results to open surgery.



PlumX Metrics


Download data is not yet available.


World Health Organization (WHO). Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019; WHO: Geneva, Switzerland, 2020.
Lipworth L, Morgans AK, Edwards TL, et al. Renal cell cancer histological subtype distribution differs by race and sex. BJU Int 2016;117:260-265. DOI:
Makino T, Kadomoto S, Izumi K, Mizokami A. Epidemiology and prevention of renal cell carcinoma. Cancers 2022;14:4059. DOI:
Capitanio U, Bensalah K, Bex A, et al. Epidemiology of renal cell carcinoma. Eur Urol 2019;75:74-84. DOI:
Ljungberg B, Bensalah K, Bex A, et al. Guidelines on renal cell carcinoma. European Association of Urology 2015. DOI:
De Meerleer G, Khoo V, Escudier B, et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol 2014;15:e170-e177. DOI:
Gunnarsson O, et al. Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma. Cancer Manag Res 2015:65-73. DOI:
Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy. New Eng J Med 1991;324:1370-1. DOI:
Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European association of urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol 2019;75:799-810. DOI:
Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol 1963;89:37-42. DOI:
Novick AC, Jackson CL, Straffon RA. The role of renal autotransplantation in complex urological reconstruction. J Urol 1990;143:452-7. DOI:
Sagalowsky AI, Kadesky KT, Ewalt DM, Kennedy TJ, et al. Factors influencing adrenal metastasis in renal cell carcinoma. J Urol 1994;151:1181-4. DOI:
Dimarco DS, Lohse CM, Zincke H, et al. Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy. Urology 2004;64:462-7. DOI:
Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol 2017;197:S182-S186. DOI:
Hemal A, Kumar A, Kumar R, et al. Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison. J Urol 2007;177:862-6. DOI:
Peyronnet B, et al. Oncological outcomes of laparoscopic nephroureterectomy versus open radical nephroureterectomy for upper tract urothelial carcinoma: an European Association of Urology guidelines systematic review. Eur Urol Focus 2019;5:205-23. DOI:
Eskicorapci SY, Teber D, Schulze M, et al. Laparoscopic radical nephrectomy: the new gold standard surgical treatment for localized renal cell carcinoma. Scientific World Journal 2007;7:825-36. DOI:
Desai MM, et al. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol 2005;173:38-41. DOI:
Wille AH, Roigas J, Deger S, et al. Laparoscopic radical nephrectomy: techniques, results and oncological outcome in 125 consecutive cases. Eur Urol 2004;45:483-9. DOI:
Cicco A, Salomon L, Hoznek A, et al. Results of retroperitoneal laparoscopic radical nephrectomy. J Endourol 2001;15:355-9. DOI:
Hemal A, Wadhwa SN, Kumar M, Gupta NP. Transperitoneal and retroperitoneal laparoscopic nephrectomy for giant hydronephrosis. J Urol 1999;162:35-9. DOI:
Elsamra S, Pareek G. Complications of laparoscopic renal surgery. Int J Urol 2010;17:206-14. DOI:
Bilgo A, Saouli A, Karmouni T, et al. Laparoscopic nephrectomy: Moroccan experience of 68 cases. Afr J Urol 2021;27:70. DOI:
Balcı M, Tuncel A, Güzel Ö, et al. Evaluation of the complications in transperitoneal laparoscopic renal and adrenal surgery with Clavien-Dindo classification. Turkish J Urol 2016;42:70. DOI:
Portis AJ, et al. Long-term follow-up after laparoscopic radical nephrectomy. J Urol 2002;167:1257-62. DOI:

How to Cite

An, N. M., Kien, N. T., Duc, N. V., & Long, V. H. (2024). Retroperitoneal laparoscopic radical nephrectomy in the treatment of renal cancer: a 5-year single-center experience in resource-scare setting. Italian Journal of Medicine, 18(3).